{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T20:04:33Z","timestamp":1784405073256,"version":"3.55.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>There is no current consensus as to the most effective nonsurgical therapy for Peyronie\u2019s disease (PD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>This study aims to assess the benefit of penile traction therapy (PTT) when added to intralesional verapamil injections (IVIs) combined with oral L-arginine 1 g b.i.d. and pentoxifylline 400 mg t.i.d. in men with PD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Seventy-four men with PD completed 12 IVIs. Patients electing to add PTT were advised to wear the device for 2\u20138 hours daily and no longer than 2 hours per session. Subjective responses were measured using patient questionnaires. Stretched penile length (SPL) and erect penile curvature (EPC) using penile duplex ultrasound were measured. Response to therapy was defined as at least a 10-degree reduction in EPC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Change in SPL (cm) and change in EPC (degrees).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Thirty-five patients in group I vs. 39 patients in the PTT group II completed the protocol. Fifty-four percent of men in group II responded to therapy vs. 46% in group I (P = 0.75). Responders in group II had a mean EPC improvement of 26.9 degrees vs. 20.9 degrees in group I (P = 0.22). Mean PTT use was 3.3 hours per day, and men with &amp;gt;3 hours per day use gained 0.6 cm in SPL vs. 0.07 cm using less than or equal to 3 hours per day (P = 0.09), while men in group I lost 0.74 cm of SPL on average. Multivariate analysis revealed that duration of PTT use significantly predicts length gain (0.38 cm gain for every additional hour per day of PTT use, P = 0.007).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>There was a trend toward measured curvature improvement and a significant gain in SPL in men using the combination therapy protocol. Length improvement is related to duration of use of the traction device.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2011.02519.x","type":"journal-article","created":{"date-parts":[[2011,10,24]],"date-time":"2011-10-24T18:00:52Z","timestamp":1319479252000},"page":"288-295","source":"Crossref","is-referenced-by-count":90,"title":["Combination of Penile Traction, Intralesional Verapamil, and Oral Therapies for Peyronie\u2019s Disease"],"prefix":"10.1093","volume":"9","author":[{"given":"Michael R.","family":"Abern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence A.","family":"Levine","sequence":"additional","affiliation":[{"name":"Department of Urology, Rush University Medical Center , Chicago, IL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,1,1]]},"reference":[{"key":"2024032600294228200_bb0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-5347(01)65361-8","article-title":"Proposal: Trauma as the cause of the Peyronie\u2019s lesion","volume":"157","author":"Devine","year":"1997","journal-title":"J Urol"},{"key":"2024032600294228200_bb0015","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01850.x","article-title":"The management of Peyronie\u2019s disease: Evidence-based 2010 guidelines","volume":"7","author":"Ralph","year":"2010","journal-title":"J Sex Med"},{"key":"2024032600294228200_bb0020","doi-asserted-by":"crossref","first-page":"PE6","DOI":"10.1126\/stke.2002.119.pe6","article-title":"Mechanotransduction: All signals point to cytoskeleton, matrix, and integrins","volume":"2002","author":"Alenghat","year":"2002","journal-title":"Sci STKE"},{"key":"2024032600294228200_bb0025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tcb.2008.05.002","article-title":"Growth control by intracellular tension and extracellular stiffness","volume":"18","author":"Assoian","year":"2008","journal-title":"Trends Cell Biol"},{"key":"2024032600294228200_bb0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00003086-198901000-00038","article-title":"The tension-stress effect on the genesis and growth of tissues. Part 1. The influence of stability of fixation and soft-tissue preservation","volume":"238","author":"Ilazarov","year":"1989","journal-title":"Clin Orthop Relat Res"},{"key":"2024032600294228200_bb0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1054\/bjps.1997.3044","article-title":"Progressive skin extension: Clinical and histological evaluation of a modified procedure using Kirschner wires","volume":"52","author":"Molea","year":"1999","journal-title":"Br J Plast Surg"},{"key":"2024032600294228200_bb0040","first-page":"285","article-title":"Ultrastructural studies on myofibrillogenesis and neogenesis of skeletal muscles after prolonged traction in rabbits","volume":"11","author":"Sun","year":"1996","journal-title":"Histol Histopathol"},{"key":"2024032600294228200_bb0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/ten.teb.2008.0020","article-title":"Implications of tensile loading for the tissue engineering of nerves","volume":"14","author":"Bueno","year":"2008","journal-title":"Tissue Eng Part B Rev"},{"key":"2024032600294228200_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.22203\/eCM.v015a05","article-title":"Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts","volume":"15","author":"Shapiro","year":"2008","journal-title":"Eur Cell Mater"},{"key":"2024032600294228200_bb0055","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1743-6109.2007.00537.x","article-title":"A survey of primary-care physicians and urologists regarding Peyronie\u2019s disease","volume":"4","author":"LaRochelle","year":"2007","journal-title":"J Sex Med"},{"key":"2024032600294228200_bb0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.niox.2003.12.002","article-title":"L-Arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie\u2019s fibrotic plaque and related fibroblast cultures","volume":"9","author":"Valente","year":"2003","journal-title":"Nitric Oxide"},{"key":"2024032600294228200_bb0065","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1073\/pnas.93.11.5478","article-title":"Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix","volume":"93","author":"Roth","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024032600294228200_bb0070","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.ijir.3900874","article-title":"Peyronie\u2019s disease cell culture models: Phenotypic, genotypic and functional analyses","volume":"14","author":"Mulhall","year":"2002","journal-title":"Int J Impot Res"},{"key":"2024032600294228200_bb0075","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0022-5347(17)35291-6","article-title":"Intralesional verapamil injection for the treatment of Peyronie\u2019s disease","volume":"151","author":"Levine","year":"1994","journal-title":"J Urol"},{"key":"2024032600294228200_bb0080","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0090-4295(97)00700-0","article-title":"Use of intralesional verapamil to dissolve Peyronie\u2019s disease plaque: A long term single-blind study","volume":"51","author":"Rehman","year":"1998","journal-title":"Urology"},{"key":"2024032600294228200_bb0085","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.ijir.3900917","article-title":"Intralesional verapamil for the treatment of Peyronie\u2019s disease: A review","volume":"14","author":"Levine","year":"2002","journal-title":"Int J Impot Res"},{"key":"2024032600294228200_bb0090","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.urology.2007.02.042","article-title":"Intralesional verapamil prevents the progression of Peyronie\u2019s disease","volume":"69","author":"Bennett","year":"2007","journal-title":"Urology"},{"key":"2024032600294228200_bb0095","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0022-5347(01)65682-9","article-title":"Penile length in the flaccid and erect states: Guidelines for penile augmentation","volume":"156","author":"Wessells","year":"1996","journal-title":"J Urol"},{"key":"2024032600294228200_bb0100","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000019698","article-title":"Imaging modalities in Peyronie\u2019s disease. An intrapersonal comparison of ultrasound sonography, X-ray in mammography technique, computerized tomography, and nuclear magnetic resonance in 20 patients","volume":"34","author":"Andresen","year":"1998","journal-title":"Eur Urol"},{"key":"2024032600294228200_bb0105","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/0266-7681(94)90220-8","article-title":"The continuous elongation technique for severe Dupuytren\u2019s disease. A biochemical mechanism","volume":"19","author":"Bailey","year":"1994","journal-title":"J Hand Surg [Br]"},{"key":"2024032600294228200_bb0110","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/01.prs.0000182345.86453.4f","article-title":"Microarray analysis of mechanical shear effects on flexor tendon cells","volume":"116","author":"Fong","year":"2005","journal-title":"Plast Reconstr Surg"},{"key":"2024032600294228200_bb0115","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0266-7681(94)90221-6","article-title":"The palmar fascia after treatment by the continuous extension technique for Dupuytren\u2019s contracture","volume":"19","author":"Brandes","year":"1994","journal-title":"J Hand Surg [Br]"},{"key":"2024032600294228200_bb0120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.urology.2004.04.006","article-title":"Comparison of gene expression profiles between Peyronie\u2019s disease and Dupuytren\u2019s contracture","volume":"64","author":"Qian","year":"2004","journal-title":"Urology"},{"key":"2024032600294228200_bb0125","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1743-6109.2008.00814.x","article-title":"Penile traction therapy for treatment of Peyronie\u2019s disease: A single-center pilot study","volume":"5","author":"Levine","year":"2008","journal-title":"J Sex Med"},{"key":"2024032600294228200_bb0130","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1743-6109.2008.01108.x","article-title":"Use of penile extender device in the treatment of penile curvature as a result of Peyronie\u2019s disease. Results of a phase II prospective study","volume":"6","author":"Gontero","year":"2009","journal-title":"J Sex Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515337309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515337309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/9\/1\/288\/47770017\/jsm_9_1_288.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/9\/1\/288\/47770017\/jsm_9_1_288.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:23:08Z","timestamp":1711416188000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/9\/1\/288\/6886750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,1]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,1]]},"published-print":{"date-parts":[[2012,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02519.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2012,1]]},"published":{"date-parts":[[2012,1,1]]}}}